PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

被引：0
|
作者：
Ghaneya Al-Khadairi
Adviti Naik
Remy Thomas
Boshra Al-Sulaiti
Shaheen Rizly
Julie Decock
机构：
[1] Hamad Bin Khalifa University (HBKU),College of Health and Life Sciences (CHLS)
[2] Cancer Research Center,undefined
[3] Qatar Biomedical Research Institute (QBRI),undefined
来源：
Journal of Translational Medicine | / 17卷
关键词：
PRAME; PReferentially Antigen expressed in Melanoma; Triple negative breast cancer; Migration; Invasion; Epithelial-to-mesenchymal transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression
    Lin, Dan
    Kuang, Ge
    Wan, Jingyuan
    Zhang, Xiang
    Li, Hongzhong
    Gong, Xia
    Li, Hongyuan
    ONCOLOGY REPORTS, 2017, 37 (02) : 895 - 902
  • [22] miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer
    Lv, Zhi-Dong
    Kong, Bin
    Liu, Xiang-Ping
    Jin, Li-Ying
    Dong, Qian
    Li, Fu-Nian
    Wang, Hai-Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (05) : 864 - 873
  • [23] p66ShcA Promotes Breast Cancer Plasticity by Inducing an Epithelial-to-Mesenchymal Transition
    Hudson, Jesse
    Ha, Jacqueline R.
    Sabourin, Valerie
    Ahn, Ryuhjin
    La Selva, Rachel
    Livingstone, Julie
    Podmore, Lauren
    Knight, Jennifer
    Forrest, Laura
    Beauchemin, Nicole
    Hallett, Michael
    Park, Morag
    Ursini-Siegel, Josie
    MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (19) : 3689 - 3701
  • [24] CHFR-mediated epithelial-to-mesenchymal transition promotes metastasis in human breast cancer cells
    Jiang, Guobin
    Fang, Hongyan
    Shang, Xi
    Chen, Xiaopin
    Cao, Feilin
    MOLECULAR MEDICINE REPORTS, 2021, 23 (06)
  • [25] SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
    Qian, Shihan
    Zhu, Jingjing
    Han, Qing
    Cheng, Huang
    Zhou, Huaibin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [26] Cancer stem cell (CSC) and epithelial mesenchymal transition (EMT) in triple negative breast cancer
    Ishikawa, Y.
    Oyama, T.
    Katayama, A.
    Handa, T.
    Tokiniwa, H.
    Horiguchi, J.
    Iino, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S123 - S123
  • [27] Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition
    Bong, Alice H. L.
    Monteith, Gregory R.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2017, 87 : 23 - 26
  • [28] Evaluation of natural and synthetic compounds on epithelial to mesenchymal transition in triple negative breast cancer
    Faruk, Asef
    Patel, Saloni
    Hallak, Ramez
    Flaherty, Patrick
    Cavanaugh, Jane
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
  • [29] Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment
    Francesc Font-Clos
    Stefano Zapperi
    Caterina A. M. La Porta
    Scientific Reports, 12
  • [30] Role of epithelial-mesenchymal transition markers in triple-negative breast cancer
    Cheung, Sai Yin
    Boey, Yvonne Jia Yu
    Koh, Valerie Cui Yun
    Thike, Aye Aye
    Lim, Jeffrey Chun Tatt
    Iqbal, Jabed
    Tan, Puay Hoon
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 489 - 498
12345